🇺🇸 FDA
Patent

US 7189396

Delivery system using mAb 3E10 and mutants and/or functional fragments thereof

granted A61KA61K38/00A61K47/68

Quick answer

US patent 7189396 (Delivery system using mAb 3E10 and mutants and/or functional fragments thereof) held by The Regents of the University of California expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K47/68, A61K47/6849